Notice 19 Feb 2025 regulatory compliance, international trade, pharmaceuticals, usitc, biotechnology, trade secrets

⚖️USITC Investigation 337-TA-1352 on Trade Secrets in Pharma

Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined to review a final initial determination ("FID") issued by the presiding Chief Administrative Law Judge ("Chief ALJ"), finding a violation of section 337 of the Tariff Act of 1930, as amended. The Commission requests written submissions from the parties, interested government agencies, and other interested persons on the issues of remedy, the public interest, and bonding, under the schedule set forth below.

Learn More
Notice 19 Feb 2025 regulatory compliance, pennsylvania, pharmaceuticals, foreign-trade zone, production activity

💊Foreign-Trade Zone Notice for Piramal Pharma Solutions Production

The Department of Commerce announces Piramal Pharma Solutions' proposed production activity for cholesterol medication in Foreign-Trade Zone 35. The notification details the specific duty-free products and invites public comments, providing insight into production limitations and opportunities for businesses involved in pharmaceutical manufacturing.

Learn More
Notice 18 Feb 2025 compliance, pharmaceuticals, drug regulation, dea, controlled substances, business registration

💊Lonza Tampa

Lonza Tampa, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Learn More
Notice 18 Feb 2025 regulatory compliance, pharmaceuticals, dea, controlled substances, business registration, drug manufacturing, janssen pharmaceuticals

💊Janssen Pharmaceuticals' Application for Controlled Substances Registration

Janssen Pharmaceuticals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Learn More
Notice 18 Feb 2025 compliance, regulation, pharmaceuticals, dea, controlled substances, mylan pharmaceuticals

💊Mylan Pharmaceuticals Applies for Controlled Substances Import Registration

Mylan Pharmaceuticals, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Learn More
Notice 18 Feb 2025 business compliance, pharmaceuticals, regulatory requirements, dea, controlled substances, drug enforcement, scottsdale research institute

💊Scottsdale Research Institute Seeks Registration for Controlled Substances

Scottsdale Research Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Learn More
Notice 13 Feb 2025 regulatory compliance, dea, pharmaceuticals, business application, drug enforcement, controlled substances

💊Benuvia Operations, LLC Application for Bulk Manufacturing License

Benuvia Operations, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 13 Feb 2025 purisys, regulatory compliance, dea, pharmaceuticals, drug enforcement, controlled substances

💊Purisys LLC Importer Application Notice for Controlled Substances

Purisys, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 13 Feb 2025 regulatory compliance, pharmaceuticals, justice department, drug enforcement, controlled substances

💊Janssen Pharmaceuticals Applies for Controlled Substances Importer Registration

Janssen Pharmaceuticals Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 12 Feb 2025 puerto rico, pharmaceuticals, foreign-trade zones, regulatory compliance, production activity

💊Proposed Production Activity Notification for Lilly del Caribe, Inc.

Lilly del Caribe, Inc. submitted a notification to the Foreign-Trade Zones Board regarding a proposed production activity for pharmaceutical products in Carolina, Puerto Rico. The notice outlines the specific foreign-status materials involved and invites public comment on the proposal, detailing potential benefits associated with conducting production under FTZ procedures.

Learn More